CVS Health Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street rises on Iran war peace deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil nears two-month lows on reports of imminent US-Iran peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
CVS Health (CVS) PT Raised to $90 at RBC Capital
August 9, 2018 8:21 AM EDTRBC Capital raised its price target on CVS Health (NYSE: CVS) to $90.00 (from $84.00) while maintaining an Outperform rating.
Analyst George Hill views the updates on the Aetna transaction, PBM rebate retention, and the potential impact of regulatory changes positively and largely in-line with our positive view.
... MoreCVS Health (CVS) Tops Q2 EPS by 8c
August 8, 2018 6:57 AM EDTCVS Health (NYSE: CVS) reported Q2 EPS of $1.69, $0.08 better than the analyst estimate of $1.61. Revenue for the quarter came in at $46.7 billion versus the consensus estimate of $46.34 billion.
Same store sales increased 5.9% and pharmacy same store sales increased 8.3% in the three months ended... More
